Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation. - Wikidata - awgldk - TriplyDB

Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation.

Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation.

http://www.wikidata.org/entity/Q35523618

about

Mosaic Subventricular Origins of Forebrain Oligodendrogenesis Remyelination Therapy in Multiple Sclerosis Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?A single-nucleotide polymorphism in serine-threonine kinase 11, the gene encoding liver kinase B1, is a risk factor for multiple sclerosis Translational control of myelin basic protein expression by ERK2 MAP kinase regulates timely remyelination in the adult brain Olig1 function is required for oligodendrocyte differentiation in the mouse brain.Myelin Proteolipid Protein Complexes with αv Integrin and AMPA Receptors In Vivo and Regulates AMPA-Dependent Oligodendrocyte Progenitor Cell Migration through the Modulation of Cell-Surface GluR2 Expression.The Involvement of Mutual Inhibition of ERK and mTOR in PLCγ1-Mediated MMP-13 Expression in Human Osteoarthritis Chondrocytes.Olig1 Acetylation and Nuclear Export Mediate Oligodendrocyte Development.TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium.ERK1/2 Activation in Preexisting Oligodendrocytes of Adult Mice Drives New Myelin Synthesis and Enhanced CNS Function.Integrin-Linked Kinase (ILK) Deletion Disrupts Oligodendrocyte Development by Altering Cell Cycle Zebrafish as a model to investigate CNS myelination.mTOR in Brain Physiology and Pathologies.Gold nanoparticles enhance the differentiation of embryonic stem cells into dopaminergic neurons via mTOR/p70S6K pathway.Intracellular signaling pathway regulation of myelination and remyelination in the CNS.Signaling by FGF Receptor 2, Not FGF Receptor 1, Regulates Myelin Thickness through Activation of ERK1/2-MAPK, Which Promotes mTORC1 Activity in an Akt-Independent Manner.Fyn is an intermediate kinase that BDNF utilizes to promote oligodendrocyte myelination.Aspirin Promotes Oligodendroglial Differentiation Through Inhibition of Wnt Signaling Pathway.Mechanistic target of rapamycin is activated in bovine granulosa cells after LH surge but is not essential for ovulation.PTEN negatively regulates the cell lineage progression from NG2+ glial progenitor to oligodendrocyte via mTOR-independent signaling.

P2860

Q26752420-3686F120-A87C-4447-8D11-F6B902788F8A Q26772359-63E44273-7A00-47B0-8114-44981B4E1653 Q33911142-B0F8C84D-83BA-4BA4-98BF-1C365094D291 Q35126302-892A5C6C-C56E-43DF-9C20-435B6D899BA4 Q35625755-0FEB2AE4-820C-4F3A-BA5B-D7F5F93993EE Q35707945-B0B4B1FC-85BF-4928-86DB-C89203542BB0 Q35995980-376152E9-0D4B-406A-9355-8484DF61813A Q36076304-B84EC404-850A-42D2-9A7F-A50B2B1BC6C3 Q36339174-14581C73-3BE4-4068-BFC2-4644CE6B3969 Q36347242-60E723CF-DDB7-43DB-A6B5-D1FE76F44E70 Q37219078-7DCAF4A6-BF70-4E2F-BDB9-94B51A4F2958 Q37592138-DD088853-5497-4B27-B329-703B93F6492C Q38255026-B9C162D6-2C39-4DB8-A6F7-745A3150218B Q38565769-465D4304-6F6C-4C94-A388-8BA5E82AA5F3 Q38682364-936821B1-7D05-4230-A944-F515C214C19D Q38766318-2165BACE-8614-461F-B2CA-7846B128F0F8 Q38963348-266440E3-B8CA-4A28-B0F1-019655E8AA20 Q40451861-5E49742C-EAFC-41F2-8C4C-33993F11B11B Q40852158-1C567759-7AFF-401E-84AC-B4975551C8FF Q42497944-99826BD6-A333-424D-9484-6E9EF3B5BC93 Q49815600-5CE72DB5-14A4-48C8-95EE-FDCBE9B7688B

P2860

Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation.

http://www.wikidata.org/entity/Q35523618

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation.

@ast

Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation.

@en

type

label

Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation.

@ast

Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation.

@en

prefLabel

Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation.

@ast

Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation.

@en

P1433

Q35523618-A5A70A7E-D978-4B02-BDBB-64623BBC2F81

P1476

Q35523618-3B54A598-F7FA-408F-A0A0-6823F5A03361

P2093

Q35523618-048B04ED-BFD9-45E2-8914-5E09ECFFAD92

Q35523618-67078569-DE4C-491F-8D95-CD6ED0FF4664

Q35523618-EB449B63-651F-4D47-952E-BA674A3703B2

P2860

Q35523618-0CD1A38B-3EC7-4613-AE44-853A82207F13

Q35523618-0E357D26-D512-4023-A8DE-605E0113B994

Q35523618-163DE92F-C513-4A06-BF39-F740D79FAECE

Q35523618-193D4F8B-4B40-4C80-8F8B-DFFB40B4C972

Q35523618-21204FCA-7FCF-48C3-B2AC-A9061EE5091C

Q35523618-244D6A88-A319-42BC-A2C6-A88C312C1C4C

Q35523618-25DAE19E-4A83-44E2-AA89-5E66DDAB7A52

Q35523618-27C6F1C5-AA22-44E3-A587-AF24A0955465

Q35523618-35229EF0-A923-49DC-9E6F-2D67DDBF2D3C

Q35523618-3DEC034F-FAF1-40D2-94FD-F577CA9A5C7B

P304

Q35523618-92BA8303-3309-4983-A6B1-16F55069116F

P31

Q35523618-12ADDD66-A6FD-4861-BE64-BEC3538C94A0

P356

Q35523618-24EE8E71-5418-4612-82A1-CCE31231A5AA

P433

Q35523618-CD8BB76F-162B-414F-A42A-B5BACC1DE4DB

P478

Q35523618-5C87CE51-F8B8-42A8-B84B-599223D430D6

P577

Q35523618-D3504C25-D656-4727-A7F9-DF6CFD3F7068

P5875

Q35523618-005CF0B0-5D60-429C-89FC-B23D132E7348

P698

Q35523618-A6FFAAFE-1D64-453E-850A-DAE38BC2BC66

P921

Q35523618-E29F4E79-0AEA-45C5-AD13-20BD4FF53225

P932

Q35523618-A85F5824-5910-4055-8F70-28F678795F36

P356

P1433

P1476

Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation.

@en

P2093

JinXiang Dai

http://www.w3.org/2001/XMLSchema#string

Kathryn K Bercury

http://www.w3.org/2001/XMLSchema#string

Wendy B Macklin

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery of 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a highly potent, selective mammalian target of rapamycin (mTOR) inhibitor for the treatment of cancer

Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis

Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB

Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation

Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue

Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer

Phosphatidylinositol-3-OH kinase as a direct target of Ras

Decoding signaling and function of the orphan G protein-coupled receptor GPR17 with a small-molecule agonist

Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage

Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.

P304

2096-2109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/GLIA.22729

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264243609

http://www.w3.org/2001/XMLSchema#string

P698

25060812

http://www.w3.org/2001/XMLSchema#string

P921

oligodendrocyte

P932

4406223

http://www.w3.org/2001/XMLSchema#string